NAM Use for Regulatory Application

NURA x Emulate

Regulatory Green Light: Using Organ-on-a-Chip Technology to Meet Evolving FDA Expectations

Wednesday, September 10, 2025

11am-12pm ET / 15:00-16:00 UTC

Dr. Daniel Levner, Chief Technology Officer at Emulate, will share how the FDA’s ISTAND qualification of the Liver-Chip S1 represents a pivotal step for regulatory recognition and broader adoption of Organ-on-a-Chip technology.

Full Details & Registration

SARA-ICE: Points of Departure for Skin Sensitisation Risk Assessment with OECD GL 497.

Wednesday, October 1, 2025

10am-12pm ET / 14:00-16:00 UTC

Skin sensitisation experts Emily Reinke, PhD, and Georgia Reynolds, MSc, will join NURA to present a training on SARA-ICE that will include discussion of the new in silico method, a live demo, and a case study.

Full Details & Registration

NURA is developing several new in-person and virtual training opportunities, including:

• NAMs for Sunscreens
• A Hands-on QSAR Training
• Validation of NAMs

Join our mailing list to get updates on our latest learning opportunities. You can also use the form to provide feedback and suggest training topics. Alternatively, you can email us with your comments and suggestions at nura [at] pcrm.org. 

We would like to feature your human-based nonanimal approach in a webinar. 

You will have the opportunity to present your method to a diverse professional audience from industry, government, NGOs, and academia, followed by an audience-led Q&A session. We are looking for:

• Case studies of NAMs that have been submitted in investigational new drug (IND) applications.
• NAMs currently being used in regulatory applications or those that have the potential to replace animal use in regulatory applications.

Please submit your presentation title and abstract or speaker suggestion to nura [at] pcrm.org. 

Connect With Us